-Amyloid protein (A) is a major component of neuritic plaques and cerebrovascular amyloid deposits in the brains of patients with Alzheimer's disease (AD). Inhibitors of A fibrillogenesis are currently sought as potential future therapeutics for AD and related disorders. In the present study, the
✦ LIBER ✦
Specific binding of the alzheimer βA4 amyloid precursor to collagen, laminin, and heparin
✍ Scribed by Gerd Multhaup; Ashley I. Bush; Peter Pollwein; Colin L. Masters; Konrad Beyreuther
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 239 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1573-4943
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Laminin inhibition of β-amyloid protein
✍
Gerardo M. Castillo; Widia Lukito; Elaine Peskind; Murray Raskind; Daniel A. Kir
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 257 KB
Is the binding of β-amyloid protein to a
✍
Christine M. Lukacs; David W. Christianson
📂
Article
📅
1996
🏛
John Wiley and Sons
🌐
English
⚖ 606 KB
A growing body of experimental evidence demonstrates that the serpin antichymotrypsin plays a regulatory role in Alzheimer plaque physiology by interacting with the 42 residue p-amyloid protein, and we have used molecular modeling and energy minimization techniques to study this interaction. Based o